Nutriband
NTRB | NASDAQ
$5.81
-$0.29 (-4.75%)
At close: Nov 16, 2026, 4:00 PM ET
$6.00
+$0.19 (+3.27%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.75%
(1D)No price chart data available for 1D timeframe.
Rating
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #732/1021 (Top 72%)
Key Statistics
Market Data
Market Cap $70.62M
1D Range
5.52 6.04
52W Range
2.81 8.99
Valuation (TTM)
PE -10.19
PB 13.25
EV/EBITDA -9.90
Valuation (NTM)
Forward PE 3.79
Forward PEG 0.09
Price Target $0.00
Cash Flow
FCF Yield -5.1%
SBC Adj. FCF Yield -10.0%
SBC Impact -93.8%
Margins
Gross Margin 33.1%
Operating Margin -435.6%
FCF Margin -224.6%
Growth (CAGR)
Revenue 3Y | 5Y -10.8% |
3.1%
Dil EPS 3Y | 5Y 8.5% |
-14.1%
FCF 3Y | 5Y 7.3% |
-1.8%
Returns
ROA -110.6%
ROE -109.0%
ROIC -127.0%
Financial Health
Net Cash
$3.23M
Current Ratio 4.21
Interest Coverage -339.35
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fen...
Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date Oct 1, 2021
Website nutriband.com
Fiscal Year February - January
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NTRB